Abiopharma

New Form 8-K - Processa Pharmaceuticals, Inc. Filed: 2025-06-17 AccNo: 0001641172-25-015355 Size: 11 MB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits